ERBB2 and breast cancer: In contrast, theprognosis for the Luminal B subtype is moderate; however, in TNBCand HER2 overexpression subtypes, the prognosis is notably poorer,suggesting a higher level of challenge and a lower probability ofoverall survival.3 Similar to other malignancies,the etiology of BC is multifactorial and complicated.